Reed, Lindsay ; Indra, Radek ; Mrizova, Iveta... Reed , L , Indra , R , Mrizova , I , Moserova , M , Schmeiser , H H , Wolf , C R , Henderson , C J , Stiborova , M , Phillips , D H & Arlt , V M 2019 , ' Application of hepatic cytochrome b 5 /P450 reductase null (HBRN) mice to study the role of cytochrome b 5 in the cytochrome P450-mediated bioactivation of the anticancer drug ellipticine ' , Toxicology and Applied Pharmacology , vol. 366 , pp. 64-74 . https://doi.org/10.1016/j.taap.2019.01.020.
,
2019
Reed, Lindsay ; Indra, Radek ; Mrizova, Iveta... Reed , L , Indra , R , Mrizova , I , Moserova , M , Schmeiser , H H , Wolf , C R , Henderson , C J , Stiborova , M , Phillips , D H & Arlt , V M 2019 , ' Application of hepatic cytochrome b 5 /P450 reductase null (HBRN) mice to study the role of cytochrome b 5 in the cytochrome P450-mediated bioactivation of the anticancer drug ellipticine ' , Toxicology and Applied Pharmacology , vol. 366 , pp. 64-74 . https://doi.org/10.1016/j.taap.2019.01.020.
,
2019